Advanced search
Publication Cover
Current Medical Research and Opinion Volume 29, 2013 - Issue 12
Submit an article Journal homepage
476
Views
14
CrossRef citations to date
0
Altmetric
Diabetes: Original articles

A pooled analysis of exenatide use and risk of acute pancreatitis

David D. DoreDepartments of Health Services, Policy & Practice and Epidemiology, Brown School of Public Health Providence, RIUSA;Center for Gerontology and Health Care Research, Brown School of Public Health Providence, RIUSA;Optum Epidemiology Waltham, MAUSACorrespondence[email protected]
,
Mohamed HusseinIMS Consulting Falls Church, VAUSA
,
Clorinda HoffmanOptum Epidemiology Waltham, MAUSA
,
Elise M. PelletierIMS Consulting Falls Church, VAUSA
,
Daniel B. SmithIMS Consulting Falls Church, VAUSA
&
John D. SeegerOptum Epidemiology Waltham, MAUSA;Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School/Brigham and Women’s Hospital Boston, MAUSA
Pages 1577-1586 | Accepted 19 Aug 2013, Published online: 13 Sep 2013

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chin-Hsiao Tseng. (2015) Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan. Annals of Medicine 47:7, pages 561-569.
Read now

Articles from other publishers (13)

Kristen Wilhite, Jennifer Meyer Reid & Matthew Lane. (2023) Risk of Pancreatitis With Incretin Therapies Versus Thiazolidinediones in the Veterans Health Administration. Annals of Pharmacotherapy.
Crossref
Rohan Khera, Martijn J Schuemie, Yuan Lu, Anna Ostropolets, RuiJun Chen, George Hripcsak, Patrick B Ryan, Harlan M Krumholz & Marc A Suchard. (2022) Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies. BMJ Open 12:6, pages e057977.
Crossref
Marion L. Vetter, Kristina Johnsson, Elise Hardy, Hui Wang & Nayyar Iqbal. (2019) Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials. Diabetes Therapy 10:4, pages 1249-1270.
Crossref
Sonja S. Nakasian, Jeremy A. Rassen & Jessica M. Franklin. (2017) Effects of expanding the look-back period to all available data in the assessment of covariates. Pharmacoepidemiology and Drug Safety 26:8, pages 890-899.
Crossref
Hui Peng, Laura L. Want & Vanita R. Aroda. (2016) Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program. Current Diabetes Reports 16:5.
Crossref
Tetsuhide Ito, Hiroshi Ishiguro, Hirotaka Ohara, Terumi Kamisawa, Junichi Sakagami, Naohiro Sata, Yoshifumi Takeyama, Morihisa Hirota, Hiroyuki Miyakawa, Hisato Igarashi, Lingaku Lee, Takashi Fujiyama, Masayuki Hijioka, Keijiro Ueda, Yuichi Tachibana, Yoshio Sogame, Hiroaki Yasuda, Ryusuke Kato, Keisho Kataoka, Keiko Shiratori, Masanori Sugiyama, Kazuichi Okazaki, Shigeyuki Kawa, Yusuke Tando, Yoshikazu Kinoshita, Mamoru Watanabe & Tooru Shimosegawa. (2016) Evidence-based clinical practice guidelines for chronic pancreatitis 2015. Journal of Gastroenterology 51:2, pages 85-92.
Crossref
Giuseppe Famularo, Lelio Morviducci & Laura Gasbarrone. (2015) Pancreatitis in incretin-based therapies. Clinics and Research in Hepatology and Gastroenterology 39:3, pages e37-e38.
Crossref
Hsien-Yen Chang, Chi-Feng Hsieh, Sonal Singh, Wenze Tang, Yi-Ting Chiang & Weng-Foung Huang. (2015) Anti-diabetic therapies and the risk of acute pancreatitis: a nationwide retrospective cohort study from Taiwan. Pharmacoepidemiology and Drug Safety 24:6, pages 567-575.
Crossref
Carlo B. Giorda, Carlotta Sacerdote, Elisa Nada, Lisa Marafetti, Ileana Baldi & Roberto Gnavi. (2014) Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies. Endocrine 48:2, pages 461-471.
Crossref
Tetsuhide ITO, Lingaku LEE & Ken KAWABE. (2015) Incretin-based therapy for patients with diabetes mellitus secondary to chronic pancreatitis: An update from the 2015 Japanese guidelines of management of chronic pancreatitis. Suizo 30:6, pages 773-776.
Crossref
C. B. Giorda, E. Nada, B. Tartaglino, L. Marafetti & R. Gnavi. (2014) A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position. Diabetes, Obesity and Metabolism 16:11, pages 1041-1047.
Crossref
Michael A Nauck & Juris J Meier. (2014) Pancreatitis and incretin-based drugs: clarity or confusion?. The Lancet Diabetes & Endocrinology 2:2, pages 92-93.
Crossref
R.C.L. Page. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 763 787 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.